LatestTrump Unveils U.S. Space Force Uniform, Sparks Online Controversy Over Design Comparisons
Cannabis

Trump Grants Clemency to Federal Marijuana Prisoners as DEA Advances Cannabis Rescheduling

Tom Angell
Trump Grants Clemency to Federal Marijuana Prisoners as DEA Advances Cannabis Rescheduling
AnxietyDepressionChronic PainEpilepsyPTSD
Summary

President Trump has commuted sentences for federal marijuana convictions, including Jerry Haymon IV and Kevin Harden, as his administration progresses with DEA rescheduling efforts. This clemency action reflects shifting federal policy toward cannabis, which has been classified as Schedule I despite growing medical applications for conditions including chronic pain, epilepsy, and PTSD. The rescheduling process could expand access to medical cannabis research and treatment options for patients who currently face legal barriers. These developments signal potential reforms in federal marijuana policy that may influence therapeutic availability and criminal justice outcomes related to cannabis offenses. For Puerto Rico residents, changes in federal scheduling could impact medical marijuana access and research opportunities in the territory.

Marijuana Moment

Originally published on

Marijuana Moment

By Tom Angell

Read full article(opens in new tab)

Fetched: September 5, 2026 at 10:02 AM

More news you might be interested in

View all
Nitrous Oxide Use Rising Among Spanish Youth, But Data Does Not Support Epidemic Claims
Cannabis

Nitrous Oxide Use Rising Among Spanish Youth, But Data Does Not Support Epidemic Claims

According to the 2025 ESTUDES survey, 1.7% of Spanish students aged 14-18 have tried nitrous oxide, representing a modest increase of 0.2 percentage points since 2023. While the trend shows growth in experimentation, current epidemiological data does not yet support characterizing youth nitrous oxide use as an epidemic. Health officials emphasize the importance of continued surveillance and education regarding the neurological risks associated with chronic nitrous oxide exposure, including vitamin B12 deficiency and potential nerve damage. The findings highlight the need for evidence-based public health messaging to distinguish between emerging trends and widespread public health crises.

13 hours ago
Revista Cáñamo
Chilean Foundation Preserves Archive of Pioneering Ethnobotanist Jonathan Ott
Cannabis

Chilean Foundation Preserves Archive of Pioneering Ethnobotanist Jonathan Ott

The Lobeliana Foundation is working to preserve and import the personal library and correspondence of Jonathan Ott, a renowned ethnobotanist and writer who passed away in 2025. The collection, comprising approximately 2,500 books and extensive archival materials, is being transferred from Xalapa, Mexico to the Araucanía region of Chile. Ott was a seminal figure in ethnobotanical research and the study of entheogenic plants, substances that have garnered increasing scientific interest for their potential therapeutic applications in mental health and consciousness research. This preservation effort ensures that a crucial historical archive documenting the contemporary study of plant medicine and ethnobotany remains intact for future researchers and scholars.

13 hours ago
Revista Cáñamo
Argentina Expands Hemp Regulation with New Licenses for Flowers and Biomass
Cannabis

Argentina Expands Hemp Regulation with New Licenses for Flowers and Biomass

Argentina's Hemp and Medicinal Cannabis Regulatory Agency (ARICCAME) has approved a new regulatory framework for producing and commercializing non-psychoactive hemp inflorescences, biomass, and other plant materials. The expansion includes licensing for derivative production, third-party services, and international trade operations. This development strengthens Argentina's position as a leader in Latin America's regulated cannabis industry and creates opportunities for standardized, quality-controlled hemp products. The framework supports the medical cannabis sector by ensuring safe, traceable supply chains for therapeutic applications across the region.

14 hours ago
Revista Cáñamo
New Research Challenges Popular Belief: CBD May Not Reduce THC's Psychoactive Effects
Cannabis
AnxietyChronic Pain

New Research Challenges Popular Belief: CBD May Not Reduce THC's Psychoactive Effects

A comprehensive systematic review published in Neuroscience and Biobehavioral Reviews challenges the long-held belief that CBD mitigates THC's psychoactive effects. Contrary to popular cannabis culture wisdom, researchers found that concurrent CBD and THC consumption does not decrease systemic THC exposure and may actually increase blood levels of 11-hydroxy-THC, the cannabinoid's most potent metabolite. This finding has significant implications for patients using cannabis therapeutically for anxiety, pain management, and other conditions who have relied on high-CBD strains to moderate THC's intensity. Understanding this pharmacological interaction is crucial for healthcare providers and patients in Puerto Rico's medical marijuana program to make informed dosing decisions and strain selections.

20 hours ago
Soft Secrets (Español)